AMS microtracer studies let teams generate human ADME and mass balance data early in clinical development, while there is still time to…
On 26 March 2026, Peregrion hosted its second AMS Symposium in Leiden, bringing together delegates from pharmaceutical companies, biotech organisations, CROs…
